https://www.modernretina.com/view/opt-302-combination-therapy-with-ranibizumab-for-pcv-shows-va-gains-anatomic-improvements-in-phase-2b-trial
Ann: Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $775.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 675 | 66.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 442 | 1 |
View Market Depth
| Last trade - 10.01am 18/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |
Day chart unavailable